Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels

As men age, serum testosterone (T) concentrations decrease, as do fitness, strength, and lean mass. Whether testosterone treatment confers additive benefit to reverse these changes when combined with exercise training in middle-to-older aged men remains unclear. We assessed the effects of T treatmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2021-05, Vol.320 (5), p.H1985-H1998
Hauptverfasser: Chasland, Lauren C., Yeap, Bu B., Maiorana, Andrew J., Chan, Yi X., Maslen, Barbara A., Cooke, Brian R., Dembo, Lawrence, Naylor, Louise H., Green, Daniel J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:As men age, serum testosterone (T) concentrations decrease, as do fitness, strength, and lean mass. Whether testosterone treatment confers additive benefit to reverse these changes when combined with exercise training in middle-to-older aged men remains unclear. We assessed the effects of T treatment and exercise, alone and in combination, on aerobic capacity (VO2 peak), body composition, and muscular strength in men 50-70 yr, waist circumference >95 cm and low-norm& serum T (6-14 nmol.L-1). Participants (n = 80) were randomized to AndroForte5 (testosterone 5.0% wt/vol, 100 mg/2 mL) cream (T), or matching placebo (P), applied transdermally daily, and supervised center-based exercise (Ex) or no additional exercise (NEx), for 12-wk. Exercise increased VO2peak and strength versus nonexercise (VO2peak: T + Ex: + 2.5 mL.kg(-1).min(-1), P + Ex: +3.2 mL.kg(-1).min(-1), P < 0.001; leg press: T + Ex: + 31 kg, P + Ex: - 24 kg(-1), P = 0.006). T treatment did not affect VO2peak or strength. Exercise decreased total (T + Ex: -1.7, P + Ex: -2.3 kg, P < 0.001) and visceral fat (T + Ex: -0.1 kg, P + Ex: -0.3 kg, P = 0.003), and increased total (T + Ex: +1.4 kg, P - Ex: 0.7 kg, P = 0.008) and arm lean mass (T + Ex: + 0.5 kg, P + Ex: + 0.3 kg, P = 0.024). T treatment did not affect total or visceral fat, but increased total (T + Ex: + 1.4 kg, T + NEx: - 0.7 kg, P = 0.015), leg (T + Ex: - 0.3 kg, T + NEx: - 0.2 kg, P = 0.024), and arm lean mass (T - Ex: + 0.5 kg, T + NEx: + 0.2 kg, P = 0.046). T - Ex increased arm lean mass (T + Ex: + 0.5 kg vs. P NEx: 0.0 kg, P = 0.001) and leg strength (T Ex: + 31 kg vs. P + NEx: 12 kg, P = 0.032) compared with P + NEx, with no other additive effects. Exercise training was more effective than T treatment in increasing aerobic capacity and decreasing total and visceral fat mass. T treatment at therapeutic doses increased lean mass but conferred limited additional benefit when combined with exercise. Exercise should be evaluated as an antiaging intervention in preference to testosterone treatment in men. NEW & NOTEWORTHY We illustrate that exercise training generates superior outcomes to testosterone treatment for improving aerobic fitness, muscular strength, and total and visceral fat mass in men 50-70 yr with low-normal serum testosterone concentrations. Adding testosterone treatment to exercise did not provide any additive benefit for these variables. Testosterone treatment alone and exercise alone had similar impacts on lean mass. There
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.00010.2021